Raul Mandler's Bibliography

Peer-Reviewed Articles:

Sanjuan PM, Rice SL, Witkiewitz K, Mandler RN, Crandall C, Bogenschutz MP. Alcohol, tobacco, and drug use among emergency department patients. Drug Alcohol Depend. 2014 May 1;138:32-8. doi: 10.1016 j.drugalcdep.2014.01.025. Epub 2014 Feb 12. PubMed PMID: 24594289.

 

Metsch LR, Feaster DJ, Gooden L, Schackman BR, Matheson T, Das M, Golden MR, Huffaker S, Haynes LF, Tross S, Malotte CK, Douaihy A, Korthuis PT, Duffus WA, Henn S, Bolan R, Philip SS, Castro JG, Castellon PC, McLaughlin G, Mandler RN, Branson B, Colfax GN. Effect of risk-reduction counseling with rapid HIV testingon risk of acquiring sexually transmitted infections: the AWARE randomized clinical trial. JAMA. 2013 Oct 23;310(16):1701-10. doi: 10.1001/jama.2013.280034. PubMed PMID: 24150466.

 

Donovan DM, Bogenschutz MP, Perl H, Forcehimes A, Adinoff B, Mandler R, Oden N, Walker R. Study design to examine the potential role of assessment reactivityin the Screening, Motivational Assessment, Referral, and Treatment in Emergency Departments (SMART-ED) protocol. Addict Sci Clin Pract. 2012 Aug 28;7(1):16. doi: 10.1186/1940-0640-7-16. PubMed PMID: 23186329; PubMed Central PMCID: PMC3599426.

 

Metsch LR, Feaster DJ, Gooden L, Matheson T, Mandler RN, Haynes L, Tross S, Kyle T, Gallup D, Kosinski AS, Douaihy A, Schackman BR, Das M, Lindblad R, Erickson S, Korthuis PT, Martino S, Sorensen JL, Szapocznik J, Walensky R, Branson B, Colfax GN. Implementing Rapid HIV Testing With or Without Risk-Reduction Counseling in Drug Treatment Centers: Results of a Randomized Trial. Am J Public Health. 2012 Jun;102(6):1160-1167. Epub 2012 Apr 19. PubMed PMID: 22515871.

 

Korthuis PT, Feaster DJ, Gomez ZL, Das M, Tross S, Wiest K, Douaihy A, Mandler RN, Sorensen JL, Colfax G, McCarty D, Cohen SE, Penn PE, Lape D, Metsch LR. Injection behaviors among injection drug users in treatment: the role of hepatitis C awareness. Addict Behav. 2012 Apr;37(4):552-5. Epub 2011 Dec 14. PubMed PMID: 22209655; PubMed Central PMCID: PMC3288438.

 

Popescu BF, Parisi JE, Cabrera-Gómez JA, Newell K, Mandler RN, Pittock SJ, Lennon VA, Weinshenker BG, Lucchinetti CF. Absence of cortical demyelination in neuromyelitis optica.Neurology. 2010 Dec 7;75(23):2103-9. PubMed PMID: 21135384; PubMed Central PMCID: PMC2995539.

 

Bogenschutz MP, Donovan DM, Adinoff B, Crandall C, Forcehimes AA, Lindblad R, Mandler RN, Oden NL, Perl HI, Walker R. Design of NIDA CTN Protocol 0047: screening, motivational assessment, referral, and treatment in emergency departments (SMART-ED). Am J Drug Alcohol Abuse. 2011 Sep;37(5):417-25. PubMed PMID: 21854285; PubMed Central PMCID: PMC3168577.

 

Tross S, Campbell AN, Calsyn DA, Metsch LR, Sorensen JL, Shoptaw S, Haynes L, Woody GE, Malow RM, Brown LS Jr, Feaster DJ, Booth RE, Mandler RN, Masson C, Holmes BW, Colfax G, Brooks AJ, Hien DA, Schackman BR, Korthuis PT, Miele GM; Clinical Trials Network HIV Special Interest Group. NIDA's Clinical Trials Network: an opportunity for HIV research in community substance abuse treatment programs. Am J Drug Alcohol Abuse. 2011 Sep;37(5):283-93. PubMed PMID: 21854270.

 

Koroshetz WJ; NIH Task Force on Research in Emergency Setting. NIH and research in the emergency setting: progress, promise, and process. Ann Emerg Med. 2010 Nov;56(5):565-7. PubMed PMID: 21036296.

 

D'Onofrio G, Jauch E, Jagoda A, Allen MH, Anglin D, Barsan WG, Berger RP, Bobrow BJ, Boudreaux ED, Bushnell C, Chan YF, Currier G, Eggly S, Ichord R, Larkin GL, Laskowitz D, Neumar RW, Newman-Toker DE, Quinn J, Shear K, Todd KH, Zatzick D; Roundtable External Participants and Roundtable Steering Committee and Federal Participants. NIH Roundtable on Opportunities to Advance Research on Neurologic and Psychiatric Emergencies. Ann Emerg Med. 2010 Nov;56(5):551-64. PubMed PMID: 21036295.

 

Booth RE, Campbell BK, Mikulich-Gilbertson SK, Tillotson CJ, Choi D, Robinson J, Calsyn DA, Mandler RN, Jenkins LM, Thompson LL, Dempsey CL, Liepman MR, McCarty D. Reducing HIV-related risk behaviors among injection drug users in residential detoxification. AIDS Behav. 2011 Jan;15(1):30-44. PubMed PMID: 20652630; PubMed Central PMCID: PMC3023839.

 

Calsyn DA, Campbell AN, Crits-Christoph P, Doyle SR, Tross S, Hatch-Maillette MA, Mandler R. Men in methadone maintenance versus psychosocial outpatient treatment: differences in sexual risk behaviors and intervention effectiveness from a multisite HIV prevention intervention trial. J Addict Dis. 2010 Jul;29(3):370-82. PubMed PMID: 20635286; PubMed Central PMCID: PMC2906815.

 

Calsyn DA, Cousins SJ, Hatch-Maillette MA, Forcehimes A, Mandler R, Doyle SR, Woody G. Sex under the influence of drugs or alcohol: common for men in substance abuse treatment and associated with high-risk sexual behavior. Am J Addict. 2010 Mar-Apr;19(2):119-27. PubMed PMID: 20163383; PubMed Central PMCID: PMC2861416.

 

Tross S, Campbell AN, Cohen LR, Calsyn D, Pavlicova M, Miele GM, Hu MC, Haynes L, Nugent N, Gan W, Hatch-Maillette M, Mandler R, McLaughlin P, El-Bassel N, Crits-Christoph P, Nunes EV. Effectiveness of HIV/STD sexual risk reduction groups for women in substance abuse treatment programs: results of NIDA Clinical Trials Network Trial. J Acquir Immune Defic Syndr. 2008 Aug 15;48(5):581-9. PubMed PMID: 18645513; PubMed Central PMCID: PMC2723122.

 

Hurwitz BJ, Jeffery D, Arnason B, Bigley K, Coyle P, Goodin D, Kaba S, Kirzinger S, Lynch S, Mandler R, Mikol D, Rammohan K, Sater R, Sriram S, Thrower B, Boateng F, Jakobs P, Wash MB, Bogumil T. Tolerability and safety profile of 12- to 28-week treatment with interferon beta-1b 250 and 500 microg QOD in patients with relapsing-remitting multiple sclerosis: a multicenter, randomized, double-blind, parallel-group pilot study. Clin Ther. 2008 Jun;30(6):1102-12. PubMed PMID: 18640466.

 

Roemer SF, Parisi JE, Lennon VA, Benarroch EE, Lassmann H, Bruck W, Mandler RN, Weinshenker BG, Pittock SJ, Wingerchuk DM, Lucchinetti CF. Pattern-specific loss of aquaporin-4 immunoreactivity distinguishes neuromyelitis optica from multiple sclerosis.Brain. 2007 May;130(Pt 5):1194-205. Epub 2007 Feb 4. PubMed PMID: 17282996.

 

Mandler RN. Neuromyelitis optica – Devic’s syndrome, update. Autoimmunity Reviews 5 (2006) 537-543.

 

Bakay M, Wang Z, Melcon G, Schiltz L, Xuan J, Zhao P, Sartorelli V, Seo J, Pegoraro E, Angelini C, Shneiderman B, Escolar D, Chen YW, Winokur ST, Pachman LM, Fan C, Mandler R, Nevo Y, Gordon E, Zhu Y, Dong Y, Wang Y, Hoffman EP. Nuclear envelope dystrophies show a transcriptional fingerprint suggesting disruption of Rb-MyoD pathways in muscle regeneration.
Brain. 2006 Apr;129(Pt 4):996-1013.

 

Panitch HS, Thisted RA, Smith RA, Wynn DR, Wymer JP, Achiron A, Vollmer TL, Mandler RN, Dietrich DW, Fletcher M, Pope LE, Berg JE, Miller A; Pseudobulbar Affect in Multiple Sclerosis Study Group. Randomized, controlled trial of dextromethorphan/quinidine for pseudobulbar affect in multiple sclerosis.
Ann Neurol. 2006 May;59(5):780-7. 

 

Foster D, Falah M, Kadom N, Mandler R.  Wernicke encephalopathy after bariatric surgery: losing more than just weight. Neurology 2005; 65: 1987 (discussion 1847).

 

Russo MJ, Firestone LB, Mandler RN, Kelly JJ. Nerve conduction studies of the lateral femoral cutaneous nerve. Implications in the diagnosis of meralgia paresthetica. Am J Electroneurodiagnostic Technol 2005; 45:180-185.

 

Mitsumoto H, Bromberg M, Johnston W, Tandan R, Byock I, Lyon M, Miller RG, Appel SH, Benditt J, Bernat JL, Borasio GD, Carver AC, Clawson L, Del Bene ML, Kasarskis EJ, LeGrand SB, Mandler R, McCarthy J, Munsat T, Newman D, Sufit RL, Versenyi A. Promoting excellence in end-of-life care in ALS. Amyotroph Lateral Scler Other Motor Neuron Disord 2005; 6(3): 145-154.

 

Roh ML, Tuazon CU, Mandler R, Kwon-Chung KJ, Geist CE. Sphenocavernous syndrome associated with Schizophyllum commune infection of the sphenoid sinus. Ophthal Plast Reconstr Surg. 2005 Jan;21(1):71-4.

 

Cudkowicz ME, Shefner JM, Schoenfeld DA, Brown RH Jr, Johnson H, Qureshi M, Jacobs M, Rothstein JD, Appel SH, Pascuzzi RM, Heiman-Patterson TD, Donofrio PD, David WS, Russell JA, Tandan R, Pioro EP, Felice KJ, Rosenfeld J, Mandler RN, Sachs GM, Bradley WG, Raynor EM, Baquis GD, Belsh JM, Novella S, Goldstein J, Hulihan J; Northeast ALS Consortium. A randomized, placebo-controlled trial of topiramate in amyotrophic lateral sclerosis. Neurology. 2003 Aug 26;61(4):456-64.

 

Wilken JA, Kane R, Sullivan CL, Wallin M, Usiskin JB, Quig ME, Simsarian J, Saunders C, Crayton H, Mandler R, Kerr D, Reeves D, Fuchs K, Manning C, Keller M. The utility of computerized neuropsychological assessment of cognitive dysfunction in patients with relapsing-remitting multiple sclerosis. Mult Scler. 2003 Mar;9(2):119-27.

 

Kalman B, Mandler RN. Studies of mitochondrial DNA in Devic's disease revealed no pathogenic mutations, but polymorphisms also found in association with multiple sclerosis.
Ann Neurol. 2002 May;51(5):661-2.

 

The Transverse Myelitis Consortium Working Group (Mandler RN, co-PI). Proposed Diagnostic Criteria for Acute Transverse Myelitis. Neurology 2002;59:499-505.

 

Lucchinetti CF, Mandler RN, McGavern D, Bruck W, Gleich G, Ransohoff RM, Trebst C, Weinshenker B, Wingerchuk D, Parisi JE, Lassmann H. A role for humoral mechanisms in the pathogenesis of Devic's neuromyelitis optica. Brain. 2002 Jul;125(Pt 7):1450-61. 

 

Mandler RN, Anderson FA Jr, Miller RG, Clawson L, Cudkowicz M, Del Bene M; ALS C.A.R.E. Study Group. The ALS Patient Care Database: insights into end-of-life care in ALS. Amyotroph Lateral Scler Other Motor Neuron Disord. 2001 Dec;2(4):203-8.

 

Bromberg MB, Anderson F, Davidson M, Miller RG ; and The ALS CARE Study Group (Mandler RN, co-principal investigator). Assessing Health Status Quality of Life in ALS: Comparison of SIP/ALS-19 with the ALS Functional Rating Scale and the Short Form-12 Health Survey. Journal of Amyotrophic Lateral Sclerosisand other motor neuron disorders 2001; 57:500-504.

 

Miller RG, Moore DH 2nd, Gelinas DF, Dronsky V, Mendoza M, Barohn RJ, Bryan W, Ravits J, Yuen E, Neville H, Ringel S, Bromberg M, Petajan J, Amato AA, Jackson C, Johnson W, Mandler R, Bosch P, Smith B, Graves M, Ross M, Sorenson EJ, Kelkar P, Parry G, Olney R; Western ALS Study Group. Phase III randomized trial of gabapentin in patients with amyotrophic lateral sclerosis.
Neurology. 2001 Apr 10;56(7):843-8.

 

Mandler RN, Dencoff JD, Midani F, Ford CC, Ahmed W, Rosenberg GA. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in cerebrospinal fluid differ in multiple sclerosis and Devic's neuromyelitis optica. Brain. 2001 Mar;124(Pt 3):493-8. 

 

Miller RG, Anderson FA, Bradley WG, Bromberg MB, Brooks BR, Mitsumoto H, Munsat T, Ringel SP, and the ALS CARE Study Group (Mandler RN, co-principal investigator). The ALS patient care database: goals, design, and early results. Neurology 2000; 54 (1) 53-57.

 

Apfel SC, Schwartz S, Adornato BT et. al, for the rhNGF Clinical Investigator Group (Mandler RN, co-PI). Efficacy and Safety of Recombinant Human Nerve Growth Factor in Patients with Diabetic Polyneuropathy. A Randomized Controlled Trial. JAMA. 2000; 284:2215-2221.

 

The BDNF Study Group (Mandler RN, co-principal investigator). A controlled trial of recombinant methionyl human BDNF in ALS. Neurology 1999; 52: 1427-1433.

 

Mandler RN, Ahmed W, Dencoff JE. Devic's neuromyelitis optica: a prospective study of seven patients treated with prednisone and azathioprine. Neurology. 1998 Oct;51(4):1219-20.

 

Ross MA, Miller RG, Berchert L, Parry G, Barohn RJ, Armon C, Bryan WW, Petajan J, Stromatt S, Goodpasture J, McGuire G & the rhCNTF ALS Study Group (Mandler RN, co-principal investigator). Toward earlier diagnosis of amyotrophic lateral sclerosis: revised criteria. Neurology 1998; 50: 768-772.

 

Johnson KP, Brooks BR, Cohen JA, Ford CC, Goldstein J, Lisak RP, Myers LW, Panitch HS, Rose JW, Schiffer RB, Vollmer T, Weiner LP, Wolinsky JS & the Copolymer 1 Multiple Sclerosis Study Group (Mandler RN, co-principal investigator). Extended use of glatiramer acetate (Copaxone) is well tolerated and maintains its clinical effect on multiple sclerosis relapse rate and degree of disability. Neurology 1998; 50: 701-708.

 

Maselli RA, Agius M, Lee EK, Bakshi N, Mandler RN, Ellis W. Morvan's fibrillary chorea. Electrodiagnostic and . in vitro microelectrode findings. Ann N Y Acad Sci. 1998 May 13;841:497-500.

 

McGuire D, Garrison L, Armon C, Barohn RJ, Bryan WW, Miller R, Parry GJ, Petajan JH, Ross MA & the Syntex-Synergen ALS/CNTF Study Group (Mandler RN, co-principal investigator). A brief quality-of-life measure for ALS clinical trials based on a subset of items from the sickness impact profile. Journal of the Neurological Sciences 1997; 152: S18-S22.

 

Bakshi N, Maselli RA, Gospe SM Jr, Ellis WG, McDonald C, Mandler RN. Fulminant demyelinating neuropathy mimicking cerebral death. Muscle Nerve. 1997 Dec;20(12):1595-7. 

 

Maselli RA, Ellis W, Mandler RN, Sheikh F, Senton G, Knox S, Salari-Namin H, Agius M, Wollmann RL, Richman DP. Cluster of wound botulism in California: clinical, electrophysiologic, and pathologic study.
Muscle Nerve. 1997 Oct;20(10):1284-95. 

 

Cock H, Mandler R, Ahmed W, Schapira AH. Neuromyelitis optica (Devic's syndrome): no association with the primary mitochondrial DNA mutations found in Leber hereditary optic neuropathy.
J Neurol Neurosurg Psychiatry. 1997 Jan;62(1):85-7.

 

Hoagland RJ, Mendoza M, Armon C, Barohn RJ, Bryan WW, Goodpasture JC, Miller RG, Parry GJ, Petajan JH, Ross MA & the Syntex-Synergen Neuroscience Joint Venture rhCNTF ALS Study Group (Mandler RN, co-principal investigator). Reliability of maximal voluntary isometric contraction testing in a multicenter study of patients with amyotrophic lateral sclerosis. Muscle & Nerve 1997; 20: 691-695.

 

Mandler RN, King MK. Myeloneuropathy in POEMS syndrome. Muscle Nerve. 1996 Dec;19(12):1614-6.

 

Mandler RN, Maselli RA. Stimulated single-fiber electromyography in wound botulism.
Muscle Nerve. 1996 Sep;19(9):1171-3.

 

Miller RG, Petajan J, Bryan WW, et al, & the rhCNTF ALS Study Group (Mandler RN co-principal investigator). A placebo-controlled trial of recombinant human ciliary neurotrophic (rhCNTF) factor in amyotrophic lateral sclerosis. Annals of Neurology 1996; 39: 256-260.

 

Bryan WW, Hoagland RJ, Murphy J, et al, & the rhCNTF ALS Study Group (Mandler RN, co-investigator). Comparison of natural history with placebo treatment in patients with amyotrophic lateral sclerosis. Journal of Neurological Sciences 1996.

 

Smith JP, Hicks PS, Ortiz LR, Martinez MJ, Mandler RN. Quantitative measurement of muscle strength in the mouse. J Neurosci Methods. 1995 Nov;62(1-2):15-9.

 

Chapin JE, Davis LE, Kornfeld M, Mandler RN. Neurologic manifestations of intravascular lymphomatosis. Acta Neurol Scand. 1995 Jun;91(6):494-9. 

 

Johnson KP, Brooks BR, Cohen JA, et al, & the Copolymer 1 Multiple Sclerosis Study Group (Mandler RN, co-investigator). Copolymer 1 reduces the relapse rate and improves disability in relapsing-remitting multiple sclerosis: results of a phase III multicenter, double-blind, placebo-controlled trial. Neurology 1995; 45: 1268-1276.

 

Mandler RN, Platt MW & Bennahum D. Neurological aphorisms of Maimonides. Humane Medicine 1994; 10: 209-214.

 

Mandler RN, Davis LE, Jeffery DR, Kornfeld M. Devic's neuromyelitis optica: a clinicopathological study of 8 patients. Ann Neurol. 1993 Aug;34(2):162-8. 

 

Jeffery DR, Mandler RN, Davis LE. Transverse myelitis. Retrospective analysis of 33 cases, with differentiation of cases associated with multiple sclerosis and parainfectious events.
Arch Neurol. 1993 May;50(5):532-5. 

 

Mandler RN, Seamer LC, Domalewski MD, Bankhurst AD. Progesterone but not estrogen depolarizes natural killer cells. Nat Immun. 1993 May-Jun;12(3):128-35. 

 

Mandler RN. The Uhthoff phenomenon. Journal of Musculoskeletal Medicine 1993; 10 (10): 12-13.

 

Mandler RN, Kerrigan DP, Smart J, Kuis W, Villiger P, Lotz M. Castleman's disease in POEMS syndrome      with elevated interleukin-6. Cancer. 1992 Jun 1;69(11):2697-703. 

 

Mandler RN, Baca JM. Muscle lactate dehydrogenase activity is decreased in murine motor neuron disease.
Brain Res. 1992 Apr 3;576(2):337-8. 

 

Seamer LC, Mandler RN. Method to improve the sensitivity of flow cytometric membrane potential measurements in mouse spinal cord cells. Cytometry. 1992;13(5):545-52. 

 

Raroque HG Jr, Mandler RN, Griffey MS, Orrison WW, Kornfeld M. Neoplastic angioendotheliomatosis.
Arch Neurol. 1990 Aug;47(8):929-30.

 

Mandler RN, Schaffner AE, Novotny EA, Lange GD, Smith SV, Barker JL. Electrical and chemical excitability appear one week before birth in the embryonic rat spinal cord.
Brain Res. 1990 Jul 2;522(1):46-54.

 

Mandler RN, Seamer LC, Whitlinger D, Lennon M, Rosenberg E, Bankhurst AD. Human natural killer cells express Na+ channels. A pharmacologic flow cytometric study. J Immunol. 1990 Mar 15;144(6):2365-70. 

 

Mandler RN, Schaffner AE, Novotny EA, Lange GD, Barker JL. Flow cytometric analysis of membrane potential in embryonic rat spinal cord cells. J Neurosci Methods. 1988 Jan;22(3):203-13.

 

Mandler RN, Biddison WE, Mandler R, Serrate SA. beta-Endorphin augments the cytolytic activity and interferon production of natural killer cells. J Immunol. 1986 Feb 1;136(3):934-9.

 

Valenzuela R, Mandler R, Goren H. Immunonephelometric quantitation of central nervous system IgG daily synthesis in multiple sclerosis. Clinical evaluation using predictive value theory.
Am J Clin Pathol. 1982 Jul;78(1):22-8.

 

Mandler R, Goren H, Valenzuela R. Value of central nervous system IgG daily synthesis determination in the diagnosis of multiple sclerosis. Neurology. 1982 Mar;32(3):296-8.
 

 

 

Chapters

 

Mandler RN. Therapy of Myopathies. In: Biller J (ed). A Practical Guide to Clinical Neurology. Lippincott-Raven, Philadelphia, pp. 522-536, 1997.

 

 

Mandler RN. Myopathies. In: Textbook of Neurosurgery. Lippincott-Raven, Philadelphia. Chapter 44, pages 641-652.

 

Mandler RN, Werner J, Meister M & LaFontaine G. Alternative and complementary therapies in amyotrophic lateral sclerosis. In: Mitsumoto H and Munsat T (eds). Amyotrophic Lateral Sclerosis, A Guide to Patients and Families. Demos, New York, NY, 2001, 201-209.

 

 

Mandler RN. Myopathies. In: Biller J (2nd ed). A Practical Guide to Clinical Neurology. Lippincott-Raven, Philadelphia,  2002, in press.

 

 

Mandler RN (ed). Dysfunction of the Blood-Brain Barrier in the pathogenesis of multiple sclerosis. Proceedings of the 2001Chicago International Conference Sponsored by Serono Symposia International, USA 2002, 1-16.

 

 

Books

 

Mandler RN (ed). Proceedings of the 1998 UNM Neurology Course in Santa Fe, UNM Department of Continuing Medical Education and the UNM Department of Neurology.

 

Letters

 

Mandler RN, Kerrigan DP, Smart J, Kuis W, Villiger P & Lotz M. Comments on Castleman's disease in POEMS syndrome with elevated IL-6. A reply. Cancer 1992; 1116.

 

Webcasts

 

Mandler RN A Spanish Webcast. New Developments in the Treatment of Multiple Sclerosis. New York, NY, May, 2003

 

Mandler RN. A National TownForum on Multiple Sclerosis.  “Crossfire Auditorium of the George Washington University in Washington, DC. Moderator, Carole Simpson, from ABC News. June 2003. Tune to www.frontiersinmedicine.com/ms

 

Mandler RN (ed). Dysfunction of the Blood-Brain Barrier in the pathogenesis of multiple sclerosis Serono Symposia International Webcast.2003

 

 

Quotes

 

Mandler RN. Effectiveness of palliative care (Quote in A Supplement to Neurology Reviews; Clinical Trends & news in Neurology): April 1999: 8-9.

 

 

Abstracts and Presentations

 

Mandler RN, Valenzuela R & Goren H. Value of central nervous system daily IgG synthesis in the diagnosis of multiple sclerosis. Neurology 1981; 31 (2): 145. Presented at the American Academy of Neurology, Toronto, Ontario, Canada.

 

Mandler RN, Valenzuela R & Goren H. Quantitation of central nervous system daily IgG production by immunonephelometry. Excerpta Medica 1981; 348. Presented at the International Congress of Neurology, Kyoto, Japan.

 

Mandler RN, Tubbs RR, Mandler R & Goren H. Acetylcholine receptor-bearing cells in normal and myasthenic thymus. Neurology 1983; 33 (2): 157. Presented at the American Academy of Neurology, San Diego, CA.

 

Mandler RN, Goren H & Valenzuela R. Diagnosis of multiple sclerosis using laser immunonephelometry and isoelectric focusing. Neurology 1983; 33 (2): 123. Presented at the American Academy of Neurology, San Diego, CA.

 

Mandler RN, Serrate SA & Biddison WE. ∃-endorphin augments natural killer mediated cytolytic activity. FASEB 1984; 1689. Presented at the Federations for Experimental Biology, Annaheim, CA.

 

Mandler RN, Patronas N, Papadopoulos N, McFarlin DE & McFarland HF. Nuclear magnetic resonance imaging in multiple sclerosis. Neurology 1985; 35 (1): 252. Presented at the American Academy of Neurology, Dallas, TX.

 

McFarland HF, Patronas NJ, McFarlin DE, Mandler RN, Beall SS, Cross AH, Goodman A & Krebs H. Studies of multiple sclerosis in twins using nuclear magnetic resonance. Neurology1985; 35 (1): 137. Presented at the American Academy of Neurology, Dallas, TX.

 

Mandler RN & Barker JL. Immunoregulatory actions of ∃-endorphin. Neurology 1986; 36 (1): 186. Presented at the American Academy of Neurology, New Orleans, LA.

 

Mandler RN, Schaffner AE, Novotny EA, Lange GD & Barker JL. Flow cytometric demonstration of function Na+ channels in the developing embryonic rat nervous system. Soc for Neurosc 1986; p. 1389. Presented at the 16th Annual Meeting, Washington, DC.

 

Novotny EA, Mandler RN, Schaffner AE, Lange GD & Barker JL. Flow cytometric analysis of membrane potential in populations of embryonic rat spinal cord cells. Soc for Neurosc 1986; p. 1389. Presented at the 16th Annual Meeting, Washington, DC.

 

Schaffner AE, Mandler RN, Novotny EA, Lange GD & Barker JL. Flow cytometric analysis of membrane excitability in embryonic rat motor neurons. Soc for Neurosc 1986; p. 1389. Presented at the 16th Annual Meeting, Washington, DC.

 

Mandler RN, Schaffner AE, Novotny EA, Lange GD & Barker JL. Functional Gaba and glycine receptors precede glutamate receptors during the development of the spinal cord. Soc for Neurosc 1987; p. 1226. Presented at the 17th Annual Meeting, New Orleans, LA.

 

Schaffner AE, Mandler RN, Novotny EA, Lange GD & Barker JL. Flow cytometric analysis of a ventral-dorsal gradient in the development of batrachotoxin and kainate sensitivities in embryonic rat spinal cord. Soc for Neurosc 1987; p. 1226. Presented at the 17th Annual Meeting, New Orleans, LA.

 

Mandler RN, Somoza L, Seamer LC & Whitlinger D. Effects of excitatory neurotransmitter and Na+ channel toxins on Wobbler mouse spinal cord cell excitability. Ann Neurol 1989; 26: 442. Presented at the Child Neurology Society, San Antonio, TX.

 

Mandler RN, Seamer LC, Bankhurst AD, Lennon M, Rosenberg E & Whitlinger D. Human natural killer cells express Na+ channels. Soc Neurosci Abstracts 1989; 15 (1): 381. Presented at Soc for Neurosc, Phoenix, AZ.

 

 

Mandler RN, Schaffner AE, Novotny EA, Lange GD & Barker JL. Development of excitatory amino acid responses in the embryonic rat spinal cord. Neurology 1989; 39 (1): 156. Presented at the American Academy of Neurology, Chicago, IL.

 

Mandler RN, Domalewski MD, Somoza L, Whitlinger D & Seamer L. Developmental and topographic analyses of electrical and clinical excitability in spinal cord cells of the Wobbler mouse, a model for motor neuron disease. Neurology 1990; 40 (1): 319. Presented at the American Academy of Neurology, Miami, FL.

 

Seamer LC, Whitlinger D, Somoza L & Mandler RN. Normalizing oxonol Fluorescence distributions to cell size using forward-angle light scatter and 90o light scatter. Society for Analytical Cytology, Asheville, NC.

 

Williams C & Mandler RN. Neurological complications of POEMS syndrome and Castelman's lymphoma. Neurology 1990; 40 (1): 246. Presented at the American Academy of Neurology, Miami, FL.

 

Mandler RN, Domalewski MD, Seamer LC, Whitlinger D, Doshi R, Faris H & Bankhurst AD. Flow cytometric analysis of excitability to progesterone in purified human natural killer cells.

Society for Neuroscience 1990. Presented at the ? Annual Meeting, St. Louis, MO.

 

Mandler RN, Domalewski MD, Whitlinger D & Seamer L. Progesterone depolarizes spinal cord cells of the Wobbler mouse and normal litter mates. Ann Neurol 1990; 28: 292. Selected for presentation at the Society for Experimental Neuropathology, Atlanta, GA.

 

Romero TA, Allgood GT & Mandler RN. Karyotype of the Wobbler mouse, a model for motor neuron disease. Presented at the Soc for Advanc of Chicanos and Native Americans in Science, Carmel, CA, 1991.

 

Baca J & Mandler RN. Lactate dehydrogenase is reduced in the biceps muscle of the Wobbler mouse. Presented at the University of New Mexico Medical Students Research Day, Albuquerque, NM, 1991.

 

Allgood PC, Romero TA & Mandler RN. Flow cytometric determination of glycine receptors in spinal cord cells of experimental murine motor neuron disease. Neurology 1991; 41 (1): 313. Presented at the American Academy of Neurology, Boston, MA.

 

Baca J & Mandler RN. Muscle lactate dehydrogenase in murine motor neuron disease. Presented at The Structural Biology of Signal Transduction Symposium, the University of New Mexico School of Medicine and the Life Science Division of Los Alamos National Laboratories, Santa Fe, NM, 1991.

 

Ortiz IE, Bankhurst AD & Mandler RN. Progesterone decreases natural killer cell cytotoxic activity. Presented at American Psychiatric Association, New Orleans, LA, 1991.

 

Mandler RN & Baca JM. Biceps lactate dehydrogenase is decreased in the Wobbler mouse. Soc Neurosci Abstr 1991; 14: Part 2, 1609, New Orleans, LA.

 

Mandler RN & Lotz M. Serum and CSF IL-6 in multiple sclerosis. Ann Neurol 1991; 30 (2): 267-268. Presented at the American Neurological Association, Seattle, WA, 1991.

 

Mandler RN & Lotz M. Castleman's disease in POEMS syndrome with elevated IL-6. J Neuroimmunol 1991; Suppl 1: 39. Presented at the International Congress of Neuroimmunology, Jerusalem, Israel, October 1991.

 

Allgood PC & Mandler RN. Strychnine-sensitive glycine receptors are decrease in experimental murine motor neuron disease: a developmental and topographic study. Neurology 1992; 42 (3): 288. Presented at the American Academy of Neurology, San Diego, CA, 1992.

 

Mandler RN, Allgood PC & Wallace J. Developmental and topographic expression of glial fibrillary acidic protein cells in experimental motor neuron disease. Ann Neurol 1992; 32 (2): 280. Presented at American Neurological Association, Toronto, Ontario, Canada, 1992.

 

Mandler RN, Davis LE, Jeffery D & Kornfeld M. A clinical-pathological study of Devic's neuromyelitis optica. Ann Neurol 1992; 32 (2): 258. Presented at American Neurological Association, Toronto, Ontario, Canada, 1992.

 

Mandler RN & Allgood PC. Immunocytochemical abnormalities in a mouse model of spinal muscular atrophy. Presented at 6th Congress of the International Child Neurology Association, Buenos Aires, Argentina, 1992.

 

Lakind E, Bennahum D, Durrell C & Mandler RN. Hemichorea: an unusual manifestation of AIDS. Presented at American College of Physicians, Albuquerque, NM, 1992.

 

Mandler RN, Ortiz LR, Porragas S, Allgood PC & Wallace JA. Astrocytosis in the brain of the Wobbler mouse, a model for motor neuron disease. Presented at American Academy of Neurology, New York, NY, 1993.

 

Ortiz LR, Mandler RN, Porragas S, Allgood PC, & Wallace JA. Astrocytes are increased in the brain and spinal cord of the Wobbler mouse, a model for motor neuron disease. Presented at Soc for Advanc of Chicanos and Native Americans in Science, Carmel CA, 1992.

 

Chapin JE, Davis LE, & Mandler RN. Neurological manifestations of intravascular lymphomatosis. Presented at IVth World Congress of Neurology, Vancouver, B.C., Canada, 1993.

 

Morrison LA, Mandler RN, & Snyder RD. Hereditary Madras syndrome. Presented at XVth World Congress of Neurology, Vancouver, B.C., Canada, 1993.

 

Ortiz LR & Mandler RN. Nerve transection enhances GFAP expression in murine motor neuron disease. Presented at American Academy of Neurology, Washington, DC, 1994.

 

Mandler RN. Hormonal treatment in Kennedy's disease. Presented at Argentine Congress of Neurology, Argentine Neurological Society, Mar del Plata, Argentina, 1994.

 

Mandler RN & Friedman K. The POEMS syndrome. Neurology 1995; 45 (S4): A257. Presented at the American Academy of Neurology Annual Meeting, Seattle, WA, 1995.

 

Ross MA & the ALS/SSNJV Study Group (Mandler RN, co-principal investigator; center director). Evaluation of amyotrophic lateral sclerosis diagnostic criteria (ALSDC) for a controlled trial of recombinant human ciliary neurotrophic factor. Presented at American Academy of Neurology Annual Meeting, Seattle, WA, 1995.

 

Abdallah HY & the ALS/SSNJV Study Group (Mandler RN, co-principal investigator; center director). Pharmacokinetics of recombinant human ciliary neurotrophic factor in patients with amyotrophic lateral sclerosis. Presented at the American Academy of Neurology Annual Meeting, Seattle, WA, 1995.

 

Bryan WW & the ALS/SSNJV Study Group (Mandler RN, co-principal investigator; center director). Placebo versus natural history in an ALS clinical trial. Presented at the American Academy of Neurology Annual Meeting, Seattle, WA, 1995.

 

Miller RG & the ALS/SSNJV Study Group (Mandler RN, co-principal investigator; center director). A controlled trial of recombinant human ciliary neurotrophic factor in amyotrophic lateral sclerosis. Presented at the American Academy of Neurology Annual Meeting, Seattle, WA, 1995.

 

Mandler RN & Werner J. Hormonal treatment in Kennedy's disease. Neurology 1995; 45 (S4): A449.

 

Ahmed W & Mandler RN. Immunosuppressive therapy in Devic's neuromyelitis optica. Presented at the Annual Neuroscience Day, the University of New Mexico, 1995.

 

Ancheta J & Mandler RN. Cerebral infarction in Graves' Disease. Presented at the Annual Neuroscience Day, the University of New Mexico, 1995.

 

Mandler RN & King M. An unusual case of POEMS syndrome in neuromuscular cases. Presented at the American Academy of Neurology Annual Courses, San Francisco, CA, 1996.

 

Mandler RN & Maselli RA. Firing pattern of transynaptically activated motor neurons in amyotrophic lateral sclerosis. Muscle & Nerve 1996; 19: 1209-1201. Presented at the American Association of Electrodiagnostic Medicine 43rd Annual Meeting, MN, 1996.

 

Mandler RN. Autosomal-dominant inclusion-body myopathy. Presented at the American Association of Electrodiagnostic Medicine 43rd Annual Meeting, Minneapolis, MN, 1996.

 

Maselli RA, Mandler RN, Bakshi N & Lee E-K. Morvan's fibrillary chorea: electrodiagnostic and in-vitro microelectrode findings. Muscle & Nerve 1996; 19: 1223. Presented at the American Association of Electrodiagnostic Medicine 43rd Annual Meeting, Minneapolis, MN, 1996.

 

Mandler RN & Maselli RA. Synaptic pathophysiology in amyotrophic lateral sclerosis. Presented at the 7th International Symposium on Amyotrophic Lateral Sclerosis/Motor Neuron Diseases, Chicago, IL, 1996.

 

Maselli RA & Mandler RN. Onset of amyotrophic lateral sclerosis ten years after an acute episode of transverse myelitis in a young patient. Presented at the 7th International Symposium on Amyotrophic Lateral Sclerosis/Motor Neuron Diseases, Chicago, IL, 1996.

 

Maselli RA, Bakshi N & Mandler RN. Pediatric Guillain-Barre presenting as locked-in syndrome. Presented at the American Association of Electrodiagnostic Medicine 43rd Annual Meeting, Minneapolis, MN, 1996.

 

Werner J, Mandler RN, Maidan L, & Chung S. Successful therapy of opsoclonus-SIADH with immunotherapy. Presented at the American Academy of Neurology Annual Meeting, Boston, MA, 1997.

 

Maselli RA, Agius M & Mandler RN. Marvan's fibrillary chorea. Presented at the World Conference of Myasthenia Gravis, Santa Monica, CA, 1997.

 

Wooley JM, Ringel SP & BDNF Study Group (Mandler RN, co-principal investigator). Health resource utilization and the cost of care in ALS. Presented at the VIII MND/ALS International Symposium, Glasgow, U.K., 1997.

 

Wooley JM, Ringel SP & BDNF Study Group (Mandler RN, co-principal investigator). Caregiver quality of life in ALS: relationship between patient health status and caregiver health-related quality of life, role satisfaction, and workforce participation. Presented at the VIII MND/ALS International Symposium, Glasgow, U.K., 1997.

 

Bayliss Ms, Woolley JM, Keller SD, Ware JE, & Amgen Incorporated (Mandler RN, co-principal investigator). Health-related quality of life in ALS: trends and comparisons with other chronic diseases. Presented at the VIII MND/ALS International Symposium, Glasgow, U.K., 1997.

 

Mandler RN & Brooks WM. Quantitative proton magnetic resonance spectroscopy in MND. Presented at the VIII MND/ALS International Symposium, Glasgow, U.K., 1997.

 

Mandler RN, Meister M, & Werner J. Electrodiagnostic features in a novel, familial inclusion body myopathy. Presented at the Annual Meeting of the American Association of Electrodiagnostic Medicine, San Diego, CA, 1997.

 

Mandler RN, Ahmed W, Agius M, Dencoff JE, & Rosenberg GA. Devic's neuromyelitis optica: pathogenic characteristics and favorable response to immunotherapy in 6 acute patients. Presented at the Meeting for ACTRIMS: Americas Committee for Treatment and Research in Multiple Sclerosis, Basic and Clinical Issues in Multiple Sclerosis Research, National Multiple Sclerosis Society, satellite meeting of the American Neurological Association, San Diego, CA, 1997.

 

Mandler RN, Petropolous H, Dencoff JE, Meister M, Werner J & Brooks WM. Quantitative spin-spin relaxation rate analysis in patients with ALS. Neurology 1998; 50: A30-31. Presented at the Annual Meeting of the American Academy of Neurology, Minneapolis, MN, 1998.

 

Mandler RN, Clawson LL & the ALS-CARE Study Group. The ALS patient care database: caregivers' perspective on effectiveness of palliative care. Presented at the Annual Meeting of the International Motor Neuron Disease/ALS Association, Munich, Germany, 1998.

 

Yi IS, Mandler RN & Moneim M. Carpal tunnel release in patients with hypothyroidism and diabetes mellitus: an outcome study using quality of life measures and nerve conduction studies. Presented at the American Academy of Orthopaedic Surgeons, Anaheim, CA, 1998.

 

Mandler RN. Current understanding of neuromuscular disorders. Presented at the conference on Update and Review of Internal Medicine Conference, Albuquerque, NM, 1998.

 

Mandler RN. Current understanding of neuromuscular disorders. Questions and answers at conference on Update and Review of Internal Medicine Conference, Albuquerque, NM, 1998

 

Sufit RL, Anderson F, Brooke MH, Mitsumoto H, Parry G, Ringel S, & the ALS CARE Study Group (Mandler RN, co-principal investigator). Prevalence and treatment of sialorrhea in amyotrophic lateral sclerosis (ALS) patients. Presented at the Annual Meeting of the International Motor Neuron Disease/ALS Association, Munich, Germany, 1998.

 

Miller RG, Anderson F, on behalf of the ALS CARE Study Group (Mandler RN, co-principal investigator). Assessing quality of life in ALS: comparison of the short form with the ALS functional rating scale, forced vital capacity, and ALS quality of life index. Presented at the Annual Meeting of the International Motor Neuron Disease/ALS Association, Munich, Germany, 1998.

 

Del Bene ML, Albert S, Boynton de Sepulveda L, Forshew DA, Jacobs R, Parks MB, Polak M, Richman J, Clawson LL & the ALS CARE Study Group (Mandler RN, co-principal investigator). Assessment of self reported stressors in ALS: effect of age and disease severity. Presented at the Annual Meeting of the International Motor Neuron Disease/ALS Association, Munich, Germany, 1998.

 

Cashman NR, White C, Anderson F & the ALS CARE Study Group (Mandler RN, co-principal investigator). Later presentation of amyotrophic lateral sclerosis (ALS) in women in the ALS patient care database: a neuroprotective influence of estrogen? Presented at the Annual Meeting of the International Motor Neuron Disease/ALS Association, Munich, Germany, 1998.

 

Petropoulos H, Mandler RN, Qualls C, Dencoff J, Meister M, Werner J & Brooks WM. T2relaxation in amyotrophic lateral sclerosis: a marker of disease activity. Society of Magnetic Resonance Medicine, 1999.

 

Mandler RN. Platform: Magnetic spectroscopy surrogate markers in amyotrophic lateral sclerosis. Presented at the 51st American Academy of Neurology, Toronto, Ontario, Canada, 1999.

 

Mandler RN, Clawson L, Miller RG & the ALS CARE Group. The ALS patient care database: insights into end-of-life palliative care. Presented at the 124th Annual Meeting of the American Neurological Association, Seattle, WA, 1999.

 

Lucchinetti CF, Mandler RN, Weinshenker B, Wingerchuk D, Parisi J, Lassmann H. Platform: Humoral mechanisms in the pathogenesis of Devic’s neuromyelitis optica. Presented at the 52ndAmerican Academy of Neurology Annual Meeting. San Diego, CA, May 2000.

 

Mazia C, Mandler RN. The effect of plasmapheresis in myasthenic crisis. Myasthenia gravis Foundation of America, ANA; Boston, 2000.

 

Anderson FA Jr, Miller RG, and the ALS CARE Advisory Board. (Mandler RN, Co-PI) The value of databases in ALS: The ALS Patient Care Database experience. Proceedings of the 12thInternational Symposium on ALS/MND. Oakland, November 18-20, 2001;2 (Suppl 2); abstract:C39;27 

Boynton-De Sepulveda L, Sufit RL, and the ALS CARE Study Group (Mandler RN, Co-PI). Identification of psychological well-being and depression in an ALS population and those factors influencing its presentation. Proceedings of the 12th International Symposium on ALS/MND. Oakland, November 18-20, 2001;2 (Suppl 2); abstractC70;48 

Bradley WG, Anderson FA Jr, Bromberg MB, Gutmann L, Harati Y, Ross MA, Miller RG. and the ALS CARE Advisory Board. (Mandler RN, Co-PI) Discrepancies between recent management practices in ALS and AAN evidence-based practice parameters, as revealed by the ALS Patient Care Database. Proceedings of the 11th International Symposium on ALS/MND. Arhaus, December 4-6, 2000 

Cashman NR, Cudkowicz ME, Davidson MC, Pioro EP, Rosenfeld J, and the ALS CARE Study Group.(Mandler RN, Co-PI) Gender effects on duration and onset age of Amyotrophic Lateral Sclerosis. Proceedings of the12th International Symposium on ALS/MND. Oakland, November 18-20, 2001;2 (Suppl 2); abstractC60;41. 

Cashman NR, White C, Anderson FA Jr, and the ALS CARE Study Group .(Mandler RN, Co-PI). Gender and presentation age in the ALS Patient Care Database. Neurology. 2000;52(Suppl 2):A166 

Cashman NR, White C, Anderson FA Jr, and the ALS CARE Study Group .(Mandler RN, Co-PI). Comorbid conditions in patients with Amyotrophic Lateral Sclerosis (ALS) in the ALS Patient Care Database. Proceedings of the 10th International Symposium on ALS/MND. Vancouver, November 8-10, 1999 

Cashman NR, White C, Anderson FA Jr, and the ALS CARE Study Group .(Mandler RN, Co-PI). Later presentation age in women in the ALS Patient Care Database. Proceedings of the 10thInternational Symposium on ALS/MND. Vancouver, November 8-10, 2000 

Cudkowicz M, Graves M, Miller RG, Boyton de Sepulveda L, Lessard D, Davidson MC, Anderson FA Jr, and the ALS CARE Study Group .(Mandler RN, Co-PI). Effect of Riluzole use on survival, pulmonary and functional status in a cohort of ALS patients. Proceedings of the 11th International Symposium on ALS/MND. Arhaus, December 4-6, 2000 

Mandler RN, Clawson L, Miller RG, and the ALS CARE Study Group. The ALS Patient Care Database: Insights into end-of-life palliative care in Amyotropic Lateral Sclerosis. Ann Neurol. 1999;46(3):506 

Mandler RN, Clawson L, and the ALS CARE Study Group. The ALS Patient Care Database: Caregivers’ perspective on effectiveness of palliative care. Proceedings of the 9th International Symposium on ALS/MND. Munich, November 16-18, 1998 

Miller RG, Anderson FA Jr, Bradley WG, Brooks BR, Mitsumoto H, Munsat TL, Ringel, SP, and the ALS CARE Study Group .(Mandler RN, Co-PI). The ALS Patient Care Database: A resource for measuring and improving ALS outcomes. Neurology. 1998;50(Suppl 4):A245 

Miller RG, Bromberg MB, Anderson FA Jr, and the ALS CARE Study Group .(Mandler RN, Co-PI). Assessing the quality of life in ALS: Comparison of the Short Form-12 Health Survey with the ALS Functional Rating Scale, forced vital capacity and ALS Quality of Life Index. Proceedings of the 8th International Symposium on ALS/MND. Glasgow, November 2-4, 1997 

Mitsumoto H, Davidson MC, Moore D, Brandis M, Del Bene M, Cashman NR, Ringel SP, Rosenfeld J, Shefner J, Strong M, Anderson FA Jr. .( and the ALS CARE Study Group Mandler RN, Co-PI) PEG utilization in participants of the ALS Patient Care Database. Neurology. 2001;56(Suppl 3): A201 

Ross MA, Bradley WG, Heinman-Patterson T, Lyon M, Singleton C, Lessard D. and the ALS CARE Study Group and the ALS CARE Study Group . (Mandler RN, Co-PI).The ALS caregiver – Insights from the ALS Patient Care Database. Proceedings of the 10th International Symposium on ALS/MND. Vancouver, November 8-10, 1999 

Ross MA, Bryan W, Hoagland R, Brooks BR, Harati Y, Parry G, Miller RG, and the ALS CARE Study Group(Mandler RN, Co-PI). Application of the El Escorial ALS diagnostic criteria in clinical practice. Neurology. 1999;52(6) Suppl 2:A163 

Sufit RL, Miller RG, Mitsumoto H, Parry G, Ringel SP, Lessard D, and the ALS CARE Study Group. (Mandler RN, Co-PI). Prevalence and treatment of sialorrhea in Amyotrophic Lateral Sclerosis patients as assessed by the ALS Patient Care Database. Ann Neurol. 1999;46(3):506 

Bouri K, Nazarian MJ, Brandoli C, Joslin T, Devaney J, Pegoraro E, Angelini C, Mandler RN, Escolar DM, Hoffman EP. Gene Expression Profiling identifies RNA Regulation Defects in Amyotrophic Lateral Sclerosis. Accepted. Platform Presentation . American Academy of Neurology; 2002. Denver, Colorado. Neurology 2002:58 (suppl 3), A79

Mitsumoto H, Bromberg M, Johnston W, Tandan R, and the ALS Peer Workgroup (Mandler RN, Co-PI). Filling the Gaps in End-of-Life Care in ALS: Report of the RWJ Foundation ALS Peer Workgroup. Neurology 2002:58 (suppl 3), A78

Bradley W, Anderson F, Bromberg M, et al., and the ALS CARE Study Group (Mandler RN, Co PI). Changes in Management of ALS Since Publication of AAN Practice Parameter: Evidence from the ALS Patient Care Database. Neurology 2002:58 (suppl 3), A78.

Cashman NR, Cudkowicz ME, Davidson MC, Mandler RN, Pioro EP, Rosenfeld J, and the ALS CARE Study Group. Amyotrophic Lateral Sclerosis: Impact of Gender on Disease Onset Age and Duration. Neurology 2002:58 (suppl 3), A413.

Mandler RN, Choi JM, Kingery ER, Barber A. Levetiracetam (Keppra) Improves Cerebellar Tremor in Multiple Sclerosis. 55th Annual Meeting of the American Academy of Neurology, April 1003, Hawaii, USA.

Mandler RN, Silver S, Pan J. Complementary and Alternative Medicine and the People with Multiple Sclerosis. 55th Annual Meeting of the American Academy of Neurology, April 1003, Hawaii, USA.